Muribaculum intestinale negatively impacts glioma growth in mice through the toll-like receptor 2
Top Cited Papers
Open Access
- 30 January 2026
- journal article
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2623349
Abstract
Glioblastoma (GBM) is the most common and malignant brain tumor in adult humans. Recent studies have demonstrated a link between the composition of the gut microbiota and glioma progression. Here, we describe that the growth of glioma in mice is inversely correlated with the relative abundance of the anaerobic bacterium Muribaculum intestinale in the feces. We found that M. intestinale administration: 1) induced an inflammatory environment in the gut; 2) reduced glioma growth; 3) increased the pro-inflammatory profile of tumor-associated microglial cells and the frequency of CD8+ T cells; and 4) increased the peripheral TNF-α levels. The effects induced by M. intestinale administration were significantly attenuated upon toll-like receptor 2 (TLR2) silencing using TLR2-targeting siRNA. As a pattern-recognition receptor, TLR2 detects microbial-associated molecular patterns and orchestrates host immune responses to infection. Collectively, these data demonstrate that M. intestinale induces a pro-inflammatory response in glioma bearing mice, inhibiting tumor growth via TLR2-dependent signaling.Keywords
Funding Information
- Italian Ministry of University and Research
- European Union
- Italian Ministry of Health
- Associazione Italiana per la Ricerca sul Cancro
This publication has 59 references indexed in Scilit:
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- The Role of TLR2 in Infection and ImmunityFrontiers in Immunology, 2012
- TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive FunctionThe Journal of Immunology, 2011
- The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human MicrobiotaScience, 2011
- Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disordersWorld Journal of Gastrointestinal Pathophysiology, 2011
- Imbalance of NKp44+NKp46− and NKp44−NKp46+ Natural Killer Cells in the Intestinal Mucosa of Patients With Crohn's DiseaseGastroenterology, 2010
- Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRtNature Protocols, 2009
- TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastomaCancer Gene Therapy, 2008
- Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly.1991
- Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.The Journal of Immunology, 1987